|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/24 |
| (11) | Number of the document | 1716232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05713310.0 |
| Date of filing the European patent application | 2005-02-10 | |
| (97) | Date of publication of the European application | 2006-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2010-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/004286 |
| Date | 2005-02-10 |
| (87) | Number | WO 2005/078077 |
| Date | 2005-08-25 |
| (30) | Number | Date | Country code |
| 543812 P | 2004-02-10 | US |
| (72) |
LEBOWITZ, Jonathan, US
MAGA, John, US
|
| (73) |
ZyStor Therapeutics , Inc.,
10437 Innovation Drive, Suite 100, Milwaukee, WI 53226-4838,
US
|
| (54) | ACID ALPHA-GLUCOSIDASE AND FRAGMENTS THEREOF |
| ACID ALPHA-GLUCOSIDASE AND FRAGMENTS THEREOF |